Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Alina Wein"'
Autor:
Vladimir Riabov, Qingyu Xu, Nanni Schmitt, Alexander Streuer, Guo Ge, Lyndsey Bolanos, Mark Wunderlich, Johann-Christoph Jann, Alina Wein, Eva Altrock, Marie Demmerle, Sanjay Mukherjee, Abdullah Mahmood Ali, Felicitas Rapp, Verena Nowak, Nadine Weimer, Julia Obländer, Iris Palme, Melda Göl, Ahmed Jawhar, Ali Darwich, Patrick Wuchter, Christel Weiss, Azra Raza, Jason M. Foulks, Daniel T. Starczynowski, Feng-Chun Yang, Georgia Metzgeroth, Laurenz Steiner, Mohamad Jawhar, Wolf-Karsten Hofmann, Daniel Nowak
Publikováno v:
Haematologica, Vol 109, Iss 5 (2023)
Inhibitors of anti-apoptotic BCL-2 family proteins in combination with chemotherapy and hypomethylating agents (HMA) are promising therapeutic approaches in acute myeloid leukemia (AML) and high-risk myelodysplastic syndromes (MDS). Alvocidib, a cycl
Externí odkaz:
https://doaj.org/article/587fe7bf73e84c44b2b804ab4433a656
Autor:
Vladimir Riabov, Qingyu Xu, Nanni Schmitt, Alexander Streuer, Guo Ge, Johann-Christoph Jann, Alina Wein, Eva Altrock, Felicitas Rapp, Verena Nowak, Nadine Weimer, Julia Obländer, Iris Palme, Melda Göl, Mark Wunderlich, Ahmed Jawhar, Ali Darwich, Patrick Wuchter, Christel Weiss, Jason M Foulks, Daniel T. Starczynowski, Feng-Chun Yang, Georgia Metzgeroth, Laurenz Steiner, Wolf-Karsten Hofmann, Daniel Nowak, Mohamad Jawhar
Publikováno v:
Blood. 140:9749-9750
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f17853153caf5c748fcc44c88a303b13
https://doi.org/10.1182/blood-2022-165298
https://doi.org/10.1182/blood-2022-165298
Autor:
Vladimir Ryabov, Nanni Schmitt, Qingyu Xu, Alexander Streuer, Johann-Christoph Jann, Alina Wein, Eva Altrock, Verena Nowak, Nadine Weimer, Julia Obländer, Iris Palme, Ahmed Jawhar, Ali Darwich, Patrick Wuchter, Christel Weiss, Georgia Metzgeroth, Jason M. Foulks, Laurenz Steiner, Mohamad Jawhar, Wolf-Karsten Hofmann, Daniel Nowak
Publikováno v:
Cancer Research. 82:6257-6257
The hypomethylating agent 5-azacytidine (5-Aza) is a standard-of-care for patients with higher-risk myelodysplastic syndromes (MDS). Although an initial response is induced in approximately 50% of 5-Aza treated patients, subsequent relapse is almost
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ac53bb004ddb1f30ec7380c208c38b1
https://doi.org/10.1158/1538-7445.am2022-6257
https://doi.org/10.1158/1538-7445.am2022-6257
Autor:
Christel Weiss, Verena Nowak, Wolf-Karsten Hofmann, Arwin Mehralivand, Georgia Metzgeroth, Daniel Nowak, Jason M. Foulks, Johann-Christoph Jann, Julia Obländer, Mohamad Jawhar, Nanni Schmitt, Nadine Weimer, Vladimir Riabov, Iris Palme, Qingyu Xu, Eva Altrock, Alina Wein, Alexander Streuer
Publikováno v:
Blood. 138:4649-4649
Hypomethylating therapy with 5-azacytidine (5-Aza) is a standard-of-care for patients with higher-risk myelodysplastic syndromes (MDS). Response is induced in approximately 50% of 5-Aza treated patients. However, despite robust efficacy in responders
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac355a752ed1fd5a410d6ff38acd51fe
https://doi.org/10.1182/blood-2021-150778
https://doi.org/10.1182/blood-2021-150778
Autor:
Ingo Fohmann, Alina Weinmann, Fabian Schumacher, Simon Peters, Agata Prell, Cynthia Weigel, Sarah Spiegel, Burkhard Kleuser, Alexandra Schubert-Unkmeir
Publikováno v:
PLoS Pathogens, Vol 19, Iss 11, p e1011842 (2023)
Invasion of brain endothelial cells (BECs) is central to the pathogenicity of Neisseria meningitidis infection. Here, we established a key role for the bioactive sphingolipid sphingosine-1-phosphate (S1P) and S1P receptor (S1PR) 2 in the uptake proce
Externí odkaz:
https://doaj.org/article/c31e77c4fec344e8933a84ec410cf0cc